Business, energy, technology, markets and global industry news from Business News Today

aortic stenosis

PharmaDeviceNews aortic stenosis
Representative image: A transcatheter aortic valve system in a modern cardiac catheterisation laboratory, highlighting Thubrikar Aortic Valve’s expanded Optimum TAVI CE Mark trial and European partnership with MAC’s MEDICAL Group.
Medical Devices & Diagnostics

Thubrikar Aortic Valve expands Optimum TAVI CE Mark trial with MAC’s MEDICAL Group

See how Thubrikar Aortic Valve’s MAC’s MEDICAL deal could accelerate the Optimum TAVI System’s CE Mark path and European rollout.

Read More
Corvention targets balloon aortic valvuloplasty gap with FDA-cleared KardiaPSI device
Medical Devices & Diagnostics

FDA clears Corvention’s KardiaPSI Balloon Catheter as structural heart tools get more specialized

Calcified aortic valves need force and control. Corvention’s KardiaPSI clearance tests whether niche BAV tools can scale clinically.

Read More
Representative image: A bioprosthetic aortic valve in a surgical setting highlights the growing focus on long-term heart valve durability as Edwards Lifesciences’ 10-year RESILIA tissue data sharpen the debate over lifetime valve planning in aortic stenosis care.
Medical Devices & Diagnostics

Edwards Lifesciences’ RESILIA data may shift the valve debate, but not without caveats

Valve durability is becoming a lifetime-care question. Edwards Lifesciences’ 10-year RESILIA data raise the stakes for heart teams.

Read More